JP2016535724A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016535724A5 JP2016535724A5 JP2016520025A JP2016520025A JP2016535724A5 JP 2016535724 A5 JP2016535724 A5 JP 2016535724A5 JP 2016520025 A JP2016520025 A JP 2016520025A JP 2016520025 A JP2016520025 A JP 2016520025A JP 2016535724 A5 JP2016535724 A5 JP 2016535724A5
- Authority
- JP
- Japan
- Prior art keywords
- solution
- human milk
- neutral human
- chromatography
- moving bed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000243 solution Substances 0.000 claims description 57
- 235000020256 human milk Nutrition 0.000 claims description 53
- 210000004251 human milk Anatomy 0.000 claims description 53
- 230000007935 neutral effect Effects 0.000 claims description 53
- 229920001542 oligosaccharide Polymers 0.000 claims description 49
- 150000002482 oligosaccharides Chemical class 0.000 claims description 49
- 238000000034 method Methods 0.000 claims description 36
- 238000004587 chromatography analysis Methods 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 238000000746 purification Methods 0.000 claims description 13
- 239000012045 crude solution Substances 0.000 claims description 11
- 238000000855 fermentation Methods 0.000 claims description 11
- 230000004151 fermentation Effects 0.000 claims description 11
- 230000000813 microbial effect Effects 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 9
- 239000000356 contaminant Substances 0.000 claims description 8
- 238000000502 dialysis Methods 0.000 claims description 7
- 238000001728 nano-filtration Methods 0.000 claims description 6
- 238000005571 anion exchange chromatography Methods 0.000 claims description 5
- 238000001694 spray drying Methods 0.000 claims description 5
- 239000003480 eluent Substances 0.000 claims description 4
- 239000002198 insoluble material Substances 0.000 claims description 4
- 239000012607 strong cation exchange resin Substances 0.000 claims description 4
- 239000012608 weak cation exchange resin Substances 0.000 claims description 4
- 150000001768 cations Chemical class 0.000 claims description 3
- 150000004044 tetrasaccharides Chemical class 0.000 claims description 3
- 150000004043 trisaccharides Chemical class 0.000 claims description 3
- 238000005349 anion exchange Methods 0.000 claims description 2
- 230000002210 biocatalytic effect Effects 0.000 claims description 2
- 238000006243 chemical reaction Methods 0.000 claims description 2
- 238000011210 chromatographic step Methods 0.000 claims description 2
- 238000011013 endotoxin removal Methods 0.000 claims description 2
- 239000012535 impurity Substances 0.000 claims description 2
- 238000004255 ion exchange chromatography Methods 0.000 claims description 2
- 238000003786 synthesis reaction Methods 0.000 claims description 2
- 238000005341 cation exchange Methods 0.000 claims 1
- 244000005700 microbiome Species 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
- AXQLFFDZXPOFPO-UHFFFAOYSA-N UNPD216 Natural products O1C(CO)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(=O)C)C1OC(C1O)C(O)C(CO)OC1OC1C(O)C(O)C(O)OC1CO AXQLFFDZXPOFPO-UHFFFAOYSA-N 0.000 description 7
- AXQLFFDZXPOFPO-UNTPKZLMSA-N beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp Chemical compound O([C@@H]1O[C@H](CO)[C@H](O)[C@@H]([C@H]1O)O[C@H]1[C@@H]([C@H]([C@H](O)[C@@H](CO)O1)O[C@H]1[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O1)O)NC(=O)C)[C@H]1[C@H](O)[C@@H](O)[C@H](O)O[C@@H]1CO AXQLFFDZXPOFPO-UNTPKZLMSA-N 0.000 description 7
- USIPEGYTBGEPJN-UHFFFAOYSA-N lacto-N-tetraose Natural products O1C(CO)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(=O)C)C1OC1C(O)C(CO)OC(OC(C(O)CO)C(O)C(O)C=O)C1O USIPEGYTBGEPJN-UHFFFAOYSA-N 0.000 description 7
- 238000005277 cation exchange chromatography Methods 0.000 description 6
- 229940062827 2'-fucosyllactose Drugs 0.000 description 5
- HWHQUWQCBPAQQH-UHFFFAOYSA-N 2-O-alpha-L-Fucosyl-lactose Natural products OC1C(O)C(O)C(C)OC1OC1C(O)C(O)C(CO)OC1OC(C(O)CO)C(O)C(O)C=O HWHQUWQCBPAQQH-UHFFFAOYSA-N 0.000 description 5
- HWHQUWQCBPAQQH-BWRPKUOHSA-N 2-fucosyllactose Chemical group O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O HWHQUWQCBPAQQH-BWRPKUOHSA-N 0.000 description 5
- SNFSYLYCDAVZGP-UHFFFAOYSA-N UNPD26986 Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(OC(O)C(O)C2O)CO)OC(CO)C(O)C1O SNFSYLYCDAVZGP-UHFFFAOYSA-N 0.000 description 5
- 238000009295 crossflow filtration Methods 0.000 description 5
- 238000011026 diafiltration Methods 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 239000000654 additive Substances 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- ODDPRQJTYDIWJU-UHFFFAOYSA-N 3'-beta-D-galactopyranosyl-lactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(OC(O)C(O)C2O)CO)OC(CO)C1O ODDPRQJTYDIWJU-UHFFFAOYSA-N 0.000 description 2
- AUNPEJDACLEKSC-ZAYDSPBTSA-N 3-fucosyllactose Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)O[C@H](CO)[C@@H]1O AUNPEJDACLEKSC-ZAYDSPBTSA-N 0.000 description 2
- WJPIUUDKRHCAEL-UHFFFAOYSA-N 3FL Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)OC(O)C1O WJPIUUDKRHCAEL-UHFFFAOYSA-N 0.000 description 2
- TVVLIFCVJJSLBL-SEHWTJTBSA-N Lacto-N-fucopentaose V Chemical compound O[C@H]1C(O)C(O)[C@H](C)O[C@H]1OC([C@@H](O)C=O)[C@@H](C(O)CO)O[C@H]1[C@H](O)[C@@H](OC2[C@@H](C(OC3[C@@H](C(O)C(O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](O)[C@@H](CO)O1 TVVLIFCVJJSLBL-SEHWTJTBSA-N 0.000 description 2
- RJTOFDPWCJDYFZ-SPVZFZGWSA-N Lacto-N-triaose Chemical compound CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@@H]1O RJTOFDPWCJDYFZ-SPVZFZGWSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- FZIVHOUANIQOMU-YIHIYSSUSA-N alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]([C@H](O[C@@H]3[C@H]([C@H](O[C@@H]4[C@H](OC(O)[C@H](O)[C@H]4O)CO)O[C@H](CO)[C@@H]3O)O)O[C@H](CO)[C@H]2O)NC(C)=O)O[C@H](CO)[C@H](O)[C@@H]1O FZIVHOUANIQOMU-YIHIYSSUSA-N 0.000 description 2
- CMQZRJBJDCVIEY-JEOLMMCMSA-N alpha-L-Fucp-(1->3)-[beta-D-Galp-(1->4)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](CO)O[C@@H](O[C@@H]2[C@H]([C@H](O[C@@H]3[C@H](OC(O)[C@H](O)[C@H]3O)CO)O[C@H](CO)[C@@H]2O)O)[C@@H]1NC(C)=O CMQZRJBJDCVIEY-JEOLMMCMSA-N 0.000 description 2
- RQNFGIWYOACERD-OCQMRBNYSA-N alpha-L-Fucp-(1->4)-[alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](CO)O[C@@H](O[C@@H]3[C@H]([C@H](O[C@@H]4[C@H](OC(O)[C@H](O)[C@H]4O)CO)O[C@H](CO)[C@@H]3O)O)[C@@H]2NC(C)=O)O[C@H]2[C@H]([C@H](O)[C@H](O)[C@H](C)O2)O)O[C@H](CO)[C@H](O)[C@@H]1O RQNFGIWYOACERD-OCQMRBNYSA-N 0.000 description 2
- DUKURNFHYQXCJG-JEOLMMCMSA-N alpha-L-Fucp-(1->4)-[beta-D-Galp-(1->3)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](NC(C)=O)[C@H](O[C@@H]2[C@H]([C@H](O[C@@H]3[C@H](OC(O)[C@H](O)[C@H]3O)CO)O[C@H](CO)[C@@H]2O)O)O[C@@H]1CO DUKURNFHYQXCJG-JEOLMMCMSA-N 0.000 description 2
- NPPRJALWPIXIHO-PNCMPRLYSA-N beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-[beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->6)]-beta-D-Gal-(1->4)-D-Glc Chemical compound O([C@H]1[C@H](O)[C@H]([C@@H](O[C@@H]1CO)OC[C@@H]1[C@@H]([C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O[C@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)[C@@H](CO)O2)NC(C)=O)[C@@H](O)[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)O1)O)NC(=O)C)[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O NPPRJALWPIXIHO-PNCMPRLYSA-N 0.000 description 2
- DMYPRRDPOMGEAK-XWDFSUOISA-N beta-D-Galp-(1->3)-[alpha-L-Fucp-(1->4)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-Glcp Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O[C@H]4[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O4)O)[C@H](O[C@H]4[C@H]([C@H](O)[C@H](O)[C@H](C)O4)O)[C@@H](CO)O3)NC(C)=O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](CO)OC(O)[C@@H]1O DMYPRRDPOMGEAK-XWDFSUOISA-N 0.000 description 2
- ODDPRQJTYDIWJU-OAUIKNEUSA-N beta-D-Galp-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)O[C@H](CO)[C@@H]1O ODDPRQJTYDIWJU-OAUIKNEUSA-N 0.000 description 2
- UTVHXMGRNOOVTB-IXBJWXGWSA-N beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp Chemical compound O([C@H]1[C@H](O)[C@H]([C@@H](O[C@@H]1CO)O[C@@H]1[C@H]([C@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3[C@H]([C@H](O[C@@H]4[C@H](OC(O)[C@H](O)[C@H]4O)CO)O[C@H](CO)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)CO)O[C@H](CO)[C@@H]1O)O)NC(=O)C)[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O UTVHXMGRNOOVTB-IXBJWXGWSA-N 0.000 description 2
- 238000000909 electrodialysis Methods 0.000 description 2
- RQNFGIWYOACERD-UHFFFAOYSA-N lacto-N-Difucosylhexaose I Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(CO)OC(OC3C(C(OC4C(OC(O)C(O)C4O)CO)OC(CO)C3O)O)C2NC(C)=O)OC2C(C(O)C(O)C(C)O2)O)OC(CO)C(O)C1O RQNFGIWYOACERD-UHFFFAOYSA-N 0.000 description 2
- OQIUPKPUOLIHHS-UHFFFAOYSA-N lacto-N-difucohexaose I Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(CO)OC(OC3C(C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C3O)O)C2NC(C)=O)OC2C(C(O)C(O)C(C)O2)O)OC(CO)C(O)C1O OQIUPKPUOLIHHS-UHFFFAOYSA-N 0.000 description 2
- DMYPRRDPOMGEAK-UHFFFAOYSA-N lacto-N-difucohexaose II Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(OC3C(C(OC4C(C(O)C(O)C(CO)O4)O)C(OC4C(C(O)C(O)C(C)O4)O)C(CO)O3)NC(C)=O)C(O)C(CO)O2)O)C(CO)OC(O)C1O DMYPRRDPOMGEAK-UHFFFAOYSA-N 0.000 description 2
- FZIVHOUANIQOMU-UHFFFAOYSA-N lacto-N-fucopentaose I Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(OC3C(C(OC4C(OC(O)C(O)C4O)CO)OC(CO)C3O)O)OC(CO)C2O)NC(C)=O)OC(CO)C(O)C1O FZIVHOUANIQOMU-UHFFFAOYSA-N 0.000 description 2
- FKADDOYBRRMBPP-UHFFFAOYSA-N lacto-N-fucopentaose II Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(C)=O)C(OC2C(C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C2O)O)OC1CO FKADDOYBRRMBPP-UHFFFAOYSA-N 0.000 description 2
- CMQZRJBJDCVIEY-UHFFFAOYSA-N lacto-N-fucopentaose III Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)OC(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)C1NC(C)=O CMQZRJBJDCVIEY-UHFFFAOYSA-N 0.000 description 2
- IEQCXFNWPAHHQR-UHFFFAOYSA-N lacto-N-neotetraose Natural products OCC1OC(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)C(NC(=O)C)C(O)C1OC1OC(CO)C(O)C(O)C1O IEQCXFNWPAHHQR-UHFFFAOYSA-N 0.000 description 2
- 229940062780 lacto-n-neotetraose Drugs 0.000 description 2
- 238000001471 micro-filtration Methods 0.000 description 2
- 125000001483 monosaccharide substituent group Chemical group 0.000 description 2
- RBMYDHMFFAVMMM-PLQWBNBWSA-N neolactotetraose Chemical compound O([C@H]1[C@H](O)[C@H]([C@@H](O[C@@H]1CO)O[C@@H]1[C@H]([C@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@@H]1O)O)NC(=O)C)[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O RBMYDHMFFAVMMM-PLQWBNBWSA-N 0.000 description 2
- ZDZMLVPSYYRJNI-CYQYEHMMSA-N p-lacto-n-hexaose Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1N=C(C)O)O[C@@H]1[C@@H](O)[C@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)OC([C@@H]1O)CO[C@H]1[C@@H]([C@H](C(O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](CO)O1)O)N=C(O)C)[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O ZDZMLVPSYYRJNI-CYQYEHMMSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 description 1
- 235000006810 Caesalpinia ciliata Nutrition 0.000 description 1
- 241000059739 Caesalpinia ciliata Species 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 238000003109 Karl Fischer titration Methods 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000008452 baby food Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 238000000113 differential scanning calorimetry Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- RJMUSRYZPJIFPJ-UHFFFAOYSA-N niclosamide Chemical compound OC1=CC=C(Cl)C=C1C(=O)NC1=CC=C([N+]([O-])=O)C=C1Cl RJMUSRYZPJIFPJ-UHFFFAOYSA-N 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000000634 powder X-ray diffraction Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000011146 sterile filtration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13187369.7 | 2013-10-04 | ||
| EP13187369.7A EP2857410A1 (en) | 2013-10-04 | 2013-10-04 | Process for purification of 2´-fucosyllactose using simulated moving bed chromatography |
| PCT/EP2014/071145 WO2015049331A1 (en) | 2013-10-04 | 2014-10-02 | Process for purification of a neutral human milk oligosaccharide using simulated moving bed chromatography |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016535724A JP2016535724A (ja) | 2016-11-17 |
| JP2016535724A5 true JP2016535724A5 (enExample) | 2019-12-19 |
| JP6666243B2 JP6666243B2 (ja) | 2020-03-13 |
Family
ID=49293548
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016520025A Active JP6666243B2 (ja) | 2013-10-04 | 2014-10-02 | 擬似移動床クロマトグラフィーを用いる中性ヒトミルクオリゴ糖の精製方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US10435427B2 (enExample) |
| EP (2) | EP2857410A1 (enExample) |
| JP (1) | JP6666243B2 (enExample) |
| KR (1) | KR102298281B1 (enExample) |
| CN (2) | CN105814070A (enExample) |
| BR (1) | BR112016007342B1 (enExample) |
| DK (1) | DK3063159T3 (enExample) |
| ES (1) | ES2868249T3 (enExample) |
| MX (2) | MX373919B (enExample) |
| PH (1) | PH12016500594B1 (enExample) |
| PL (1) | PL3063159T3 (enExample) |
| RU (1) | RU2685537C2 (enExample) |
| WO (1) | WO2015049331A1 (enExample) |
Families Citing this family (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2857410A1 (en) | 2013-10-04 | 2015-04-08 | Jennewein Biotechnologie GmbH | Process for purification of 2´-fucosyllactose using simulated moving bed chromatography |
| ES2701163T3 (es) | 2014-01-20 | 2019-02-21 | Jennewein Biotechnologie Gmbh | Procedimiento para la purificación eficiente de oligosacáridos de la leche humana (HMO) neutros a partir de la fermentación microbiana |
| WO2016063262A1 (en) | 2014-10-24 | 2016-04-28 | Glycom A/S | MIXTURES OF HMOs |
| WO2017101958A1 (en) | 2015-12-18 | 2017-06-22 | Glycom A/S | Fermentative production of oligosaccharides |
| DK3445770T3 (da) | 2016-04-19 | 2026-02-23 | Glycom As | Separering af oligosaccharider fra fermenteringssuppe |
| EP3474861A4 (en) | 2016-06-24 | 2020-04-15 | Glycom A/S | COMPOUNDS COMPRISING HMOS FOR THE PREVENTION AND / OR TREATMENT OF VIRAL AND / OR BACTERIAL INFECTIONS. |
| KR101979608B1 (ko) * | 2017-04-17 | 2019-08-28 | 재단법인 탄소순환형 차세대 바이오매스 생산전환 기술연구단 | 푸코오스 분리방법 및 이를 위한 장치 |
| US20200305488A1 (en) * | 2017-07-07 | 2020-10-01 | Societe Des Produitis Nestle S.A. | Human milk fortifier |
| CN119655445A (zh) | 2017-07-12 | 2025-03-21 | 格礼卡姆股份公司 | 包含中性单糖或寡糖和酸性非碳水化合物组分的无定形混合物 |
| EP3450443A1 (en) | 2017-08-29 | 2019-03-06 | Jennewein Biotechnologie GmbH | Process for purifying sialylated oligosaccharides |
| WO2019050321A1 (ko) * | 2017-09-07 | 2019-03-14 | (주)프로테옴텍 | 다수의 검사선을 구비한 크로마토그래피용 스트립, 이를 포함하는 진단 키트 및 다수의 경쟁적 반응 측정 단계를 포함하는 정성, 반정량, 정량 분석방법 |
| CA3073332A1 (en) * | 2017-09-29 | 2019-04-04 | Frieslandcampina Nederland B.V. | Process for the purification of a neutral human milk oligosaccharide (hmo) from microbial fermentation |
| AU2018380962B2 (en) * | 2017-12-08 | 2024-12-19 | Chr. Hansen HMO GmbH | Spray-dried lacto-N-fucopentaose |
| ES3040419T3 (en) | 2017-12-08 | 2025-10-30 | Chr Hansen Hmo Gmbh | Spray-dried lacto-n-fucopentaose |
| ES3039971T3 (en) | 2017-12-08 | 2025-10-28 | Chr Hansen Hmo Gmbh | Spray-dried 3-fucosyllactose |
| EP3494807A1 (en) | 2017-12-11 | 2019-06-12 | Jennewein Biotechnologie GmbH | Spray-dried sialyllactose |
| PL3494805T3 (pl) | 2017-12-08 | 2025-10-06 | Chr. Hansen HMO GmbH | Suszone rozpyłowo tetrasacharydy |
| ES3026362T3 (en) | 2018-02-08 | 2025-06-11 | Chr Hansen Hmo Gmbh | Spray-dried mixture of human milk oligosaccharides |
| EP3546060A1 (en) * | 2018-03-27 | 2019-10-02 | DuPont Nutrition Biosciences ApS | Process for spray drying fucosyllactose solutions and related product compositions |
| WO2019160922A1 (en) * | 2018-02-19 | 2019-08-22 | Dupont Nutrition Biosciences Aps | Process for spray drying fucosyllactose solutions and related product compositions |
| MX2020011875A (es) * | 2018-05-07 | 2021-01-20 | Jennewein Biotechnologie Gmbh | Un metodo sencillo para la purificacion de lacto-n-neotetraosa (lnnt) a partir de carbohidratos obtenidos por fermentacion microbiana. |
| CN112154150A (zh) * | 2018-05-23 | 2020-12-29 | 帝斯曼知识产权资产管理有限公司 | 寡糖的生产 |
| EP3833195A1 (en) * | 2018-08-08 | 2021-06-16 | Mars Incorporated | Pet food products comprising oligosaccharides and methods of use |
| EP3867258A1 (en) | 2018-10-18 | 2021-08-25 | Basf Se | Method for obtaining crystalline 2'-fucosyllactose |
| ES2966137T3 (es) | 2018-12-19 | 2024-04-18 | Glycom As | Separación de oligosacáridos |
| EP3741770A1 (en) * | 2019-05-21 | 2020-11-25 | Jennewein Biotechnologie GmbH | Purification of oligosaccharides from a fermentation broth by using filtration |
| EP3750902A1 (en) * | 2019-06-14 | 2020-12-16 | Jennewein Biotechnologie GmbH | Process for the purification of lacto-n-neotetraose |
| US20220273016A1 (en) * | 2019-07-18 | 2022-09-01 | The Regents Of The University Of California | Human milk oligosaccharides for control of dietary response and metabolic phenotype |
| MX2022002949A (es) | 2019-09-24 | 2022-04-06 | Prolacta Bioscience Inc | Composiciones y metodos para el tratamiento de enfermedades inflamatorias e inmunes. |
| CN110672756B (zh) * | 2019-11-07 | 2020-12-29 | 江南大学 | 一种奶粉中2’-岩藻糖基乳糖含量的检测方法 |
| JP2023514026A (ja) * | 2020-01-29 | 2023-04-05 | ディーエスエム アイピー アセッツ ビー．ブイ． | ヒトミルクオリゴ糖を回収して精製する方法 |
| JP2023519115A (ja) * | 2020-03-20 | 2023-05-10 | グリコム・アクティーゼルスカブ | 固形のｈｍｏ製品を提供するための方法及びそれにより得られる固形のｈｍｏ製品 |
| KR20230022867A (ko) * | 2020-06-12 | 2023-02-16 | 바스프 에스이 | 발효 브로스의 개선된 탈염 및 올리고당과 같은 정밀 화학물질의 정제 |
| IL300573A (en) | 2020-08-14 | 2023-04-01 | Prolacta Bioscience Inc | Breast milk oligosaccharide compositions for use with bacteriotherapy |
| CN112526022A (zh) * | 2020-11-27 | 2021-03-19 | 内蒙古伊利实业集团股份有限公司 | 一种乳中母乳低聚糖的检测方法 |
| KR20230131228A (ko) | 2021-01-12 | 2023-09-12 | 프롤랙타 바이오사이언스, 인코포레이티드 | 신바이오틱 치료 요법 |
| EP4304378A1 (en) | 2021-03-09 | 2024-01-17 | FrieslandCampina Nederland B.V. | Aqueous composition comprising gos and hmo |
| CN117651602A (zh) * | 2021-06-15 | 2024-03-05 | 帝斯曼知识产权资产管理有限公司 | 从发酵液中分离人乳寡糖 |
| WO2023066907A1 (en) * | 2021-10-18 | 2023-04-27 | Dsm Ip Assets B.V. | A method for providing an amorphous hmo product by drying |
| CN117003803A (zh) | 2022-05-07 | 2023-11-07 | 山东恒鲁生物科技有限公司 | 一种三糖的新晶型 |
| CN115873051B (zh) | 2022-05-17 | 2024-06-25 | 山东恒鲁生物科技有限公司 | 三糖的新晶型 |
| CN115073539B (zh) * | 2022-07-21 | 2023-06-16 | 南京工业大学 | 一种2’-岩藻糖基乳糖分离纯化的方法 |
| CN115260255B (zh) * | 2022-08-30 | 2024-06-28 | 南京工业大学 | 一种利用模拟移动床分离纯化2’-岩藻糖基乳糖的方法 |
| WO2024130119A2 (en) | 2022-12-16 | 2024-06-20 | Prolacta Bioscience, Inc. | Synbiotic compositions for short chain fatty acid production |
| CN115856151B (zh) * | 2022-12-27 | 2025-08-12 | 深圳市中科朗健生物技术有限公司 | 一种同时测定多种人乳低聚糖的高效液相色谱检测方法 |
| US20240218084A1 (en) * | 2022-12-28 | 2024-07-04 | Heilongjiang Bayi Agricultural University | Method for purifying fomes officinalis polysaccharide by sequential simulated moving chromatography |
| CN115838390A (zh) * | 2022-12-30 | 2023-03-24 | 保龄宝生物股份有限公司 | 一种利用三组分色谱分离技术制备高含量2′-岩藻糖基乳糖的方法 |
| EP4661697A1 (en) * | 2023-02-07 | 2025-12-17 | N.V. Nutricia | Nutritional composition with improved segregation resistance |
| KR20260002698A (ko) * | 2023-04-19 | 2026-01-06 | 시에이치알. 한센 에이/에스 | 인간 모유 올리고당 |
| CN122055064A (zh) | 2023-09-12 | 2026-05-15 | 菲仕兰坎皮纳荷兰公司 | 乳细胞外囊泡富集方法 |
| CN117089503B (zh) | 2023-10-17 | 2024-01-02 | 保龄宝生物股份有限公司 | 一种大肠杆菌k-12 mg1655 blbyzt6及其应用 |
| WO2025149372A1 (en) | 2024-01-09 | 2025-07-17 | Frieslandcampina Nederland B.V. | Milk extracellular vesicle enrichment process using peg |
| CN119192253B (zh) * | 2024-09-06 | 2025-10-21 | 虹摹生物科技(上海)有限公司 | 一种岩藻糖基乳糖及其纯化方法 |
| CN120847064B (zh) * | 2025-09-23 | 2025-12-05 | 吉林省科技创新研究院有限公司 | 一种液体中微量可见异物分析鉴定方法 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0779800B2 (ja) | 1986-01-23 | 1995-08-30 | オムロン株式会社 | 電子血圧計 |
| JPH0639206B2 (ja) | 1988-04-18 | 1994-05-25 | 田村プラスチック製品株式会社 | ルーフバイザーの取り付け方法 |
| JPH02286695A (ja) | 1989-04-28 | 1990-11-26 | Sumitomo Heavy Ind Ltd | オリゴ糖の分離方法 |
| NZ240002A (en) * | 1991-09-30 | 1993-11-25 | Lactose Co Of Nz Ltd | Method of producing a dry powder containing lactose and "oligosaccharides" |
| JPH0779927B2 (ja) * | 1992-05-22 | 1995-08-30 | 川崎重工業株式会社 | 擬似移動床式液体クロマトオリゴ糖分離装置 |
| JPH06253879A (ja) | 1993-03-01 | 1994-09-13 | Snow Brand Milk Prod Co Ltd | グルクロン酸結合オリゴ糖の分離方法 |
| DE4326665C2 (de) * | 1993-08-09 | 1995-07-13 | Biotest Pharma Gmbh | Verfahren zur Sterilfiltration von Milch |
| JP3368389B2 (ja) | 1993-09-14 | 2003-01-20 | 雪印乳業株式会社 | シアル酸含有オリゴ糖の分離方法 |
| FI962204A0 (fi) * | 1996-05-24 | 1996-05-24 | Cultor Oy | Foerfarande foer fraktionering av en loesning |
| CN1242776A (zh) * | 1996-10-10 | 2000-01-26 | 尼澳斯技术股份有限公司 | 用超滤、反渗透和纳滤纯化糖类 |
| DE69734205T2 (de) | 1996-10-10 | 2006-07-06 | Neose Technologies, Inc. | Reinigung von kohlenhydraten mittels umkehrosmose und nanofiltration |
| DK1531832T3 (da) | 2002-06-28 | 2009-07-27 | Glykos Finland Oy | Terapeutiske sammensætninger til anvendelse ved profylakse eller behandling af diarré |
| EP1634599A1 (en) | 2004-08-20 | 2006-03-15 | N.V. Nutricia | Iimmune stimulatory infant nutrition |
| JP5184768B2 (ja) | 2006-09-05 | 2013-04-17 | 株式会社林原 | トレハロース高含有糖液の回収方法並びに結晶トレハロースの製造方法 |
| EP2285387B1 (en) | 2008-06-13 | 2015-10-14 | N.V. Nutricia | Nutrition for prevention of infections |
| CN101367844A (zh) * | 2008-09-17 | 2009-02-18 | 无锡绿色分离应用技术研究所有限公司 | 一种从阿拉伯胶水解液中提取阿拉伯糖的方法 |
| CA2758097A1 (en) | 2009-04-07 | 2010-10-14 | Glycom A/S | Synthesis of 2'-o-fucosyllactose |
| SG176651A1 (en) * | 2009-06-08 | 2012-01-30 | Jennewein Biotechnologie Gmbh | Hmo synthesis |
| CN101831475A (zh) * | 2010-03-24 | 2010-09-15 | 方煜宇 | 一种生产高纯度低聚半乳糖的方法 |
| CA2798675A1 (en) | 2010-06-01 | 2011-12-08 | Glycom A/S | Polymorphs of 2'-o-fucosyllactose and producing thereof |
| EP2465507A1 (en) | 2010-11-23 | 2012-06-20 | Nestec S.A. | Oligosaccharide composition for treating skin diseases |
| AU2012217650B9 (en) | 2011-02-16 | 2017-09-14 | Glycosyn LLC | Biosynthesis of human milk oligosaccharides in engineered bacteria |
| CN102676604A (zh) * | 2011-03-08 | 2012-09-19 | 保龄宝生物股份有限公司 | 一种连续模拟移动床色谱分离制备高纯度低聚半乳糖的方法 |
| EP2707379A4 (en) * | 2011-05-13 | 2014-10-08 | Glycosyn LLC | USE OF PURIFIED 2'-FUCOSYLLACTOSIS, 3-FUCOSYLLACTOSIS AND LACTODIFUCOTETRAOSE AS PREBIOTICS |
| CA2835989A1 (en) * | 2011-05-13 | 2012-11-22 | Glycom A/S | Diversification of human milk oligosaccharides (hmos) or precursors thereof |
| KR20140036227A (ko) * | 2011-05-13 | 2014-03-25 | 글리콤 에이/에스 | 모유 올리고사카라이드(hmo) 또는 그의 전구체의 생성 방법 |
| EP2526784A1 (en) * | 2011-05-24 | 2012-11-28 | Nestec S.A. | Milk oligosaccharide-galactooligosaccharide composition for infant formula containing the soluble oligosaccharide fraction present in milk, and having a low level of monosaccharides, and a process to produce the composition |
| EP2861609A4 (en) * | 2012-06-14 | 2015-11-04 | Glycom As | IMPROVING STABILITY AND PURITY AND INCREASING THE BIOAVAILABILITY OF HUMAN MILK OLIGOSACCHARIDES OR PRECURSORS OR MIXTURES THEREOF |
| CN103113422B (zh) * | 2013-02-06 | 2015-06-10 | 广西轻工业科学技术研究院 | 一种用模拟流动床分离精制高纯度l-阿拉伯糖、d-木糖的方法 |
| EP2857410A1 (en) | 2013-10-04 | 2015-04-08 | Jennewein Biotechnologie GmbH | Process for purification of 2´-fucosyllactose using simulated moving bed chromatography |
-
2013
- 2013-10-04 EP EP13187369.7A patent/EP2857410A1/en active Pending
-
2014
- 2014-10-02 ES ES14777665T patent/ES2868249T3/es active Active
- 2014-10-02 WO PCT/EP2014/071145 patent/WO2015049331A1/en not_active Ceased
- 2014-10-02 KR KR1020167008862A patent/KR102298281B1/ko active Active
- 2014-10-02 BR BR112016007342-8A patent/BR112016007342B1/pt active IP Right Grant
- 2014-10-02 CN CN201480054230.4A patent/CN105814070A/zh not_active Withdrawn
- 2014-10-02 CN CN201811603666.0A patent/CN109705175B/zh active Active
- 2014-10-02 DK DK14777665.2T patent/DK3063159T3/da active
- 2014-10-02 PH PH1/2016/500594A patent/PH12016500594B1/en unknown
- 2014-10-02 RU RU2016109548A patent/RU2685537C2/ru active
- 2014-10-02 PL PL14777665T patent/PL3063159T3/pl unknown
- 2014-10-02 US US15/027,047 patent/US10435427B2/en active Active
- 2014-10-02 EP EP14777665.2A patent/EP3063159B1/en not_active Revoked
- 2014-10-02 JP JP2016520025A patent/JP6666243B2/ja active Active
- 2014-10-02 MX MX2016004288A patent/MX373919B/es active IP Right Grant
-
2016
- 2016-04-01 MX MX2020004844A patent/MX2020004844A/es unknown
-
2019
- 2019-06-13 US US16/440,100 patent/US11168105B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2016109548A (ru) | Способ очистки нейтрального олигосахарида грудного молока с применением хроматографии с симулированным движением неподвижной фазы | |
| JP7384794B2 (ja) | 発酵ブロスからｌ－フコースを精製するための方法 | |
| JP5635915B2 (ja) | シアル酸結合オリゴ糖を単離する方法、及びそのようにして得られ得るシアル酸結合オリゴ糖を含む組成物 | |
| JP7670623B2 (ja) | ろ過の使用による発酵ブロスからのオリゴ糖の精製 | |
| CN111164090A (zh) | 用于从微生物发酵纯化中性母乳寡糖（hmo）的方法 | |
| JP5843769B2 (ja) | ナノ結晶性セルロース製造からの廃液の流れの分画 | |
| FI3686211T3 (fi) | Prosessi äidinmaidon neutraalien oligosakkaridien (HMOS) tehokkaaseen puhdistamiseen mikrobifermentaatiosta | |
| JP2021524238A (ja) | オリゴ糖の生成 | |
| CN102603478B (zh) | 从赤藓糖醇多次结晶后的母液中分离提纯赤藓糖醇的方法 | |
| CN105274164A (zh) | 一种低聚半乳糖的制备方法 | |
| JP2015500643A (ja) | 動物飼料のためのメチオニン化合物 | |
| CN104448043A (zh) | 一种依诺肝素钠的生产及纯化方法 | |
| CN105440163A (zh) | 一种制备及纯化依诺肝素钠的方法 | |
| CN118027115A (zh) | 一种岩藻糖基乳糖的纯化方法 | |
| WO2006070483A1 (ja) | ジフラクトース ジアンヒドリドｉｉｉ結晶の製造方法 | |
| JP5856619B2 (ja) | イヌリンの製造方法 | |
| RU2020108730A (ru) | Способ очистки сиалилированных олигосахаридов | |
| HK40008041A (en) | Process for purification of a neutral human milk oligosaccharide using simulated moving bed chromatography | |
| HK40008041B (en) | Process for purification of a neutral human milk oligosaccharide using simulated moving bed chromatography | |
| EP4539966A1 (en) | Separation of human milk oligosaccharides from a fermentation broth | |
| HK40103782A (zh) | 使用过滤法从发酵液中纯化寡糖 | |
| CN117651602A (zh) | 从发酵液中分离人乳寡糖 | |
| HK40024600A (en) | Spray-dried tetrasaccharides | |
| DK202100635A1 (en) | Separation of neutral human milk oligosaccharides from a fermentation broth | |
| HK40059566B (zh) | 使用过滤法从发酵液中纯化寡糖 |